Posted by Michael Wonder on 16 Jan 2016
Aclidinium bromide in COPD: evidence of significant additional value in certain patients
15 January 2016 - With reference to new scientific evidence, the manufacturer requested a reassessment and submitted a new dossier.
For more details, go to: https://www.iqwig.de/de/presse/pressemitteilungen/pressemitteilungen/aclidiniumbromid-bei-copd-beleg-fur-betrachtlichen-zusatznutzen-bei-bestimmten-patienten.7140.html?&et_cid=4&et_lid=%25208
